INVESTORS

To Onyx's knowledge, all press releases, scientific papers, and abstracts and the information contained within them were timely and accurate when issued. The continued accuracy of this material beyond the date of issuance and posting on the website is not assured. Onyx has no intention of updating this information, and specifically disclaims any duty to do so. These documents may contain forward-looking statements. Actual results could vary dramatically as a result of known and unknown risks and uncertainties. Please see Terms of Use for this website.

Corporate Presentation

March 2008
[pdf file - 383 KB]

Corporate Fact Sheet

March 2008
[pdf file - 88 KB]

Stock Quote

(updated every 15 minutes)

Ticker: ONXX
Quote: 36.14 (-1.33)
Today's High: 37
Exchange: NASDAQ

Investor Relations Contacts

Julie Wood
Alexandra Santos
Onyx Pharmaceuticals, Inc.
2100 Powell Street
Emeryville, CA 94608
P: 510.597.6500
F: 510.597.6600

Latest News

May 16, 2008	Nexavar Significantly Improves Overall Survival By 47 Percent In Asia-Pacific Liver Cancer Study
May 16, 2008	Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting
May 08, 2008	Onyx Pharmaceuticals To Present At Bank Of America Health Care Conference
May 06, 2008	Onyx Pharmaceuticals Reports 2008 First Quarter Results

View More Press Releases